abstract |
The present invention relates, in some aspects, to methods of treating cancers, such as homologous recombination (RH) deficient cancers. In some embodiments, the present invention relates to a method of treating cancer by administering to a subject a compound of Formula (I): (I), or a pharmaceutically acceptable salt thereof. |